Connect Biopharma Limite... (CNTB)
1.01
-0.05 (-4.72%)
At close: Jan 15, 2025, 12:28 PM
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 |
| Net Income | -59.38M | -116.12M | -204.94M | -119.37M | -24.46M |
| Depreciation & Amortization | 988.00K | 1.01M | 640.98K | 221.05K | 114.61K |
| Stock-Based Compensation | 3.26M | 1.01M | 1.41M | 590.64K | 562.17K |
| Other Working Capital | 12.72M | 6.78M | -5.62M | -719.69K | -425.22K |
| Other Non-Cash Items | -2.28M | -1.35M | 6.91K | 443.18K | 7.69K |
| Deferred Income Tax | n/a | 3.37M | 106.37M | 89.68M | 8.30M |
| Change in Working Capital | 9.48M | 7.16M | 3.27M | -436.29K | 2.38M |
| Operating Cash Flow | -47.93M | -99.27M | -85.57M | -25.61M | -13.09M |
| Capital Expenditures | -294.00K | -4.28M | -7.46M | -2.34M | -155.52K |
| Acquisitions | 2.94M | 79.16K | 47.73K | 53.46K | 329.18 |
| Purchase of Investments | -32.60M | -113.70M | -17.98M | -16.33M | -23.65M |
| Sales Maturities Of Investments | 105.19M | 34.54M | 20.10M | 19.12M | 23.32M |
| Other Investing Acitivies | -84.00K | -79.16K | -47.74K | -53.46K | -329.18 |
| Investing Cash Flow | 75.16M | -83.44M | -5.34M | 449.15K | -484.70K |
| Debt Repayment | -290.00K | -222.00K | -126.00K | -82.42K | -63.60K |
| Common Stock Repurchased | n/a | n/a | -566.00K | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | n/a | 119.00K | -17.07M | 140.83M | 7.00K |
| Financial Cash Flow | -246.00K | -91.29K | 206.66M | 140.74M | -57.45K |
| Net Cash Flow | 27.00M | -168.93M | 109.42M | 107.40M | -13.44M |
| Free Cash Flow | -48.22M | -103.55M | -93.03M | -27.95M | -13.25M |